WallStSmart
IRMD

Iradimed Co

NASDAQ: IRMD · HEALTHCARE · MEDICAL DEVICES

$84.32
-0.53% today

Updated 2026-06-05

Market cap
$1.18B
P/E ratio
50.30
P/S ratio
13.33x
EPS (TTM)
$1.83
Dividend yield
0.82%
52W range
$54 – $107
Volume
0.1M

Iradimed Co (IRMD) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20122013201420152016201720182019202020212022202320242025
Operating cash flow$1.51M$1.47M$2.59M$7.65M$9.41M$3.42M$7.38M$10.23M$5.82M$11.26M$10.04M$13.47M$25.62M$24.95M
Capital expenditures$161561.00$191761.00$606288.00$314839.00$1.52M$824763.00$264665.00$485812.00$636746.00$741759.00$1.87M$8.01M$8.01M$7.76M
Depreciation
Stock-based comp$173240.00$271919.00$724063.00$1.22M$1.84M$2.45M$1.76M$1.85M$3.96M$1.46M$1.39M$2.19M$2.52M$2.92M
Free cash flow$1.35M$1.28M$1.98M$7.33M$7.88M$2.59M$7.11M$9.75M$5.18M$10.52M$8.17M$5.46M$17.62M$17.18M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$12.56M$12.56M$12.56M$12.56M$13.22M$13.68M$15.04M
Share repurchases
Debt repayment
Net change in cash$6.99M$9.91M$-1.65M$492105.00$9.82M$15.45M$6.59M$11.93M$-4.04M

Frequently asked questions

What is Iradimed Co's revenue?

Iradimed Co's trailing twelve-month revenue is $86.28M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is IRMD?

In its most recent fiscal year, IRMD ran a gross margin of 76.75%, an operating margin of 31.20%, and a net margin of 26.82%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does IRMD generate?

IRMD produced $17.18M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is IRMD's balance sheet healthy?

IRMD holds $51.16M in cash and equivalents against — in long-term debt, on $94.62M of shareholder equity. That debt is best read against the cash flow the business throws off each year.